AMERICAN ACADEMY OF PAIN MEDICINE
EIN: 46-5405016North Reading, MAZIP: 01864
H03 - Medical Research501(c)(3)
Mission
BASED APPROACHES IN PEROCEDURAL INTERVENTION RELATED TO CHRONIC MUSCULOSKELETAL PAIN THROUGH EDUCATION, RESEARCH, INNOVATION AND ADVOCACY.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1.4M | $0 | $958 |
| 2023 | $1.7M | $0 | $16k |
Compensation
2024
2023
Similar Organizations
CORPORATION FOR ADVANCEMENT OF MEDICAL
$1.3M revenueBoston, MA
Similar sector (H)Very similar revenue ($1.3M vs $1.4M)Same state (Massachusetts)Similar median compensation ($186k vs $205k)Similar size (2 vs 3 executives)
Intrepid Alliance Inc
$1.5M revenueCambridge, MA
Same sector (H03)Similar revenue ($1.5M vs $1.4M)Same state (Massachusetts)
TEAR FILM OCULAR SURFACE SOCIETY INC
$1.4M revenueBoston, MA
Similar sector (H)Very similar revenue ($1.4M vs $1.4M)Same state (Massachusetts)Similar median compensation ($212k vs $205k)
ONE MISSION INC
$1.5M revenueNewton, MA
Similar sector (H)Very similar revenue ($1.5M vs $1.4M)Same state (Massachusetts)
BEDFORD VA RESEARCH CORPORATION
$1.4M revenueBedford, MA
Similar sector (H)Very similar revenue ($1.4M vs $1.4M)Same state (Massachusetts)
NORTH EAST ALS CONSORTIUM INC
$1.3M revenueBoston, MA
Similar sector (H)Very similar revenue ($1.3M vs $1.4M)Same state (Massachusetts)
BEAT CHILDHOOD CANCER FOUNDATION INC
$1.6M revenueBraintree, MA
Similar sector (H)Similar revenue ($1.6M vs $1.4M)Same state (Massachusetts)Similar size (4 vs 3 executives)
MPM Oncology Charitable Foundation Inc
$1M revenueBoston, MA
Similar sector (H)Similar revenue ($1M vs $1.4M)Same state (Massachusetts)Similar size (3 vs 3 executives)
Human Proteome Organization - HUPO
$1.5M revenueNewton, MA
Similar sector (H)Similar revenue ($1.5M vs $1.4M)Same state (Massachusetts)Similar size (2 vs 3 executives)
OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION
$1.6M revenueWeston, MA
Similar sector (H)Similar revenue ($1.6M vs $1.4M)Same state (Massachusetts)
Data from IRS Form 990 filings (2023-2024).